Aurolab Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Aurolab Pharmaceutical Export Portfolio Dataset — 2 Products, $422.9K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Aurolab — Pharmaceutical Exporter Profile (2026) | 2 Products, $422.9K Trade | TransData Nexus

Aurolab

Indian Pharmaceutical Exporter · Nutritional Supplements Specialist · $422.9K Total Trade · DGFT Verified

Aurolab is an Indian pharmaceutical exporter with a total trade value of $422.9K across 2 products in 2 therapeutic categories. Based on 25 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Chondroitin ($421.0K), Gatifloxacin ($2.0K), .

Aurolab — Export Portfolio & Destination Treemap

Aurolab pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Aurolab? — Company Overview & Market Position

Established in 1992, Aurolab is a leading Indian manufacturer specializing in ophthalmic consumables, including intraocular lenses (IOLs), surgical sutures, pharmaceuticals, surgical blades, and diagnostic equipment. Operating as a non-profit charitable trust, Aurolab is an integral part of the Aravind Eye Care System, which performs over 370,000 surgeries annually, with 50% of the care provided free of charge or at below-cost rates. The company's headquarters are located at No. 1, Sivagangai Main Road, Veerapanjan, Madurai - 625 020, Tamil Nadu, India.

Aurolab's mission is to eliminate needless blindness by making high-quality ophthalmic products affordable and accessible worldwide. Over the past three decades, the company has developed a diverse portfolio of over 200 products, serving millions of patients across more than 160 countries. The company's commitment to quality is evident in its adherence to global standards, including US FDA, EU GMP, and WHO GMP norms.

What Does Aurolab Export? — Product Portfolio Analysis

Top Products by Export Value

1Chondroitin$421.0K 2

Product Portfolio — Top 2 by Export Value

Aurolab exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Chondroitin	Nutritional Supplements	$421.0K	21	8.3%	4
2	Gatifloxacin	Advanced Antibiotics	$2.0K	4	0.2%	10

Aurolab exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $422.9K. The top category is Nutritional Supplements (99.5% of portfolio), followed by Advanced Antibiotics (0.5%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Aurolab — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Aurolab's manufacturing facilities are strategically located in Madurai, Tamil Nadu, India. The company has invested in specialized facilities and capabilities for micro-machining, micro-suture manufacturing, silicon molding, metal-based manufacturing, polymer manufacturing, optics designing, wet-lab analysis, and instrumentation. These facilities are designed to meet stringent quality standards, ensuring the production of high-quality ophthalmic products. The company's commitment to quality is further demonstrated by its adherence to global standards, including US FDA, EU GMP, and WHO GMP norms.

3Key Leadership

Aurolab's leadership team is dedicated to advancing the company's mission of providing affordable and accessible eye care solutions. The Managing Director is R.D. Sriram, who oversees the company's strategic direction and operations. V. Venkatesa Kannan serves as the Head of the Pharmaceutical Division, leading the development and manufacturing of ophthalmic pharmaceuticals. (craft.co) The company's leadership is committed to innovation and quality, ensuring that Aurolab remains a trusted partner for eye care professionals worldwide.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Aurolab Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Aurolab's products are exported to over 150 countries, including the United States, European Union, United Kingdom, Australia, and Japan. The company's adherence to global standards, such as US FDA, EU GMP, and WHO GMP norms, facilitates its market access in these regulated regions. While specific regulatory filings and approvals are not publicly disclosed, Aurolab's commitment to quality and compliance positions it favorably in these markets.

2Emerging Markets

Aurolab has a significant presence in emerging markets, including Africa, Latin America, and Southeast Asia. The company's products are exported to over 150 countries, with a focus on regions such as India, Africa, Latin America, Central America, and Southeast Asia. (craft.co) Aurolab's adherence to global standards, including WHO GMP, enhances its credibility and facilitates access to these markets.

3Geographic Strategy

Aurolab's geographic strategy involves a strong focus on emerging markets, particularly in regions like Africa, Latin America, and Southeast Asia. The company's products are exported to over 150 countries, with a significant presence in these regions. (craft.co) This strategic focus allows Aurolab to address the pressing need for affordable and high-quality eye care solutions in underserved areas. The company's adherence to global standards, such as WHO GMP, further supports its expansion into these markets.

Aurolab — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Aurolab's commitment to quality is demonstrated by its adherence to US FDA standards. The company's manufacturing facilities comply with US FDA regulations, ensuring the production of high-quality ophthalmic products. While specific FDA facility registrations, approved ANDAs, DMF filings, and inspection history are not publicly disclosed, Aurolab's compliance with US FDA standards underscores its dedication to meeting stringent regulatory requirements.

2WHO & EU GMP

Aurolab's manufacturing facilities meet WHO GMP standards, ensuring the production of high-quality ophthalmic products. The company's adherence to EU GMP standards further demonstrates its commitment to quality and compliance. These certifications enable Aurolab to export its products to over 150 countries, including those in the European Union. (craft.co)

3CDSCO & Indian Regulatory

Aurolab's manufacturing facilities comply with Indian regulatory standards, including those set by the Central Drugs Standard Control Organisation (CDSCO). The company's adherence to these standards ensures the production of high-quality ophthalmic products for both domestic and international markets. Specific details regarding CDSCO manufacturing licenses, state drug controller approvals, and export NOCs are not publicly disclosed.

Aurolab — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Aurolab operates in the ophthalmic consumables market, competing with other manufacturers of intraocular lenses, surgical sutures, and related products. While specific market share data is not publicly available, Aurolab's commitment to quality and affordability positions it as a strong competitor in the global market. The company's adherence to global standards, such as US FDA, EU GMP, and WHO GMP norms, further enhances its competitive edge.

2Key Differentiators

Aurolab's key differentiators include its commitment to affordability, high-quality manufacturing, and adherence to global standards. The company's products are exported to over 150 countries, with a significant presence in emerging markets such as Africa, Latin America, and Southeast Asia. (craft.co) Aurolab's focus on innovation and quality ensures that its products meet the needs of both urban and remote settings.

3Strategic Position

Aurolab's strategic direction focuses on providing affordable and high-quality ophthalmic solutions to a global market. The company's product portfolio includes intraocular lenses, surgical sutures, pharmaceuticals, surgical blades, and diagnostic equipment. Aurolab's adherence to global standards, such as US FDA, EU GMP, and WHO GMP norms, supports its expansion into both emerging and developed markets. (craft.co)

Buyer Due Diligence Brief — Evaluating Aurolab as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Aurolab has a strong track record in manufacturing and exporting ophthalmic consumables. The company's products are exported to over 150 countries, with a significant presence in emerging markets such as Africa, Latin America, and Southeast Asia. (craft.co) Aurolab's adherence to global standards, including US FDA, EU GMP, and WHO GMP norms, ensures the reliability and consistency of its products.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and compliance:

FDA Registration: Confirm that Aurolab's manufacturing facilities are registered with the US FDA.

WHO GMP Certification: Ensure that Aurolab's facilities meet WHO Good Manufacturing Practices.

EU GMP Certification: Verify that Aurolab's facilities comply with EU Good Manufacturing Practices.

Frequently Asked Questions — Aurolab

How many pharmaceutical products does Aurolab export from India?

Aurolab exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Chondroitin ($421.0K), Gatifloxacin ($2.0K). Total export value is $422.9K.

What is Aurolab's total pharmaceutical export value?

Aurolab's total pharmaceutical export value is $422.9K, based on 25 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Aurolab cover?

Aurolab exports across 2 therapeutic categories. The largest are Nutritional Supplements (99.5%, 1 products), Advanced Antibiotics (0.5%, 1 products).

Get Full Aurolab Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.